Clinical studies recruiting near Santa Monica

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Eli Lilly and Company · NCT07218380 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · UCLA Hematology/Oncology- Santa Monica · Pfizer · NCT07028853 A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Phase 3 · Santa Monica Clinical Trials · Harmony Biosciences Management, Inc. · NCT07500090 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · Takeda · NCT06671496 A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1 · Santa Monica UCLA Medical Center & Orthopaedic Hospital · Pfizer · NCT07090499 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Eli Lilly and Company · NCT06890598 A Study of ZW251 in Participants With Advanced Solid Tumors
Phase 1 · University of California Los Angeles - Cancer Care - Santa M · Zymeworks BC Inc. · NCT07164313 Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Phase 2/Phase 3 · UCLA Health - Santa Monica Cancer Care · Exelixis · NCT06943755 Endotypic Traits and Obstructive Sleep Apnea Surgery
Phase 2 · UCLA Santa Monica Medical Center · University of California, Los Angeles · NCT05953610 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · UCLA Hematology/Oncology - Santa Monica · Bristol-Myers Squibb · NCT06561386 Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Im
Phase 1/Phase 2 · UCLA - Santa Monica /ID# 271690 · AbbVie · NCT06772623 Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Phase 1 · UCLA Health - Santa Monica Cancer Care · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · NCT06343402 A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Phase 1 · UCLA Hematology/Oncology - Santa Monica · Conjupro Biotherapeutics, Inc. · NCT05948865 A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Phase 1 · UCLA Santa Monica Hematology Oncology · Astellas Pharma Inc · NCT07094204 Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Phase 1 · UCLA Santa Monica · SystImmune Inc. · NCT05983432 A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Phase 1/Phase 2 · UCLA Santa Monica Cancer Care · BeOne Medicines · NCT05006716 A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
Phase 1 · UCLA Hematology/Oncology - Santa Monica · MediLink Therapeutics (Suzhou) Co., Ltd. · NCT06859762 A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-108
Phase 3 · UCLA Hematology/Oncology - Santa Monica ( Site 0088) · Merck Sharp & Dohme LLC · NCT06997497 A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal
Phase 1 · UCLA Dept of Medicine - Hematology/Oncology, Santa Monica · Astellas Pharma Global Development, Inc. · NCT05365581 A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Signif
Phase 2/Phase 3 · UCLA Hematology/Oncology - Santa Monica · Pfizer · NCT06989437 CRS Questionnaire Validation Project
Phase N/A · UCLA Santa Monica Medical Center · The European Forum for Research and Education in Allergy and · NCT06970977 Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Phase 1/Phase 2 · Revolution Medicines, Inc. · NCT06445062 A Study of Pitolisant in Patients With Prader-Willi Syndrome
Phase 3 · Harmony Biosciences Management, Inc. · NCT06366464 A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · UCLA Health Santa Monica Cancer Care · Bayer · NCT06452277 A Study of ASP3082 in Adults With Advanced Solid Tumors
Phase 1 · UCLA Santa Monica Hematology Oncology · Astellas Pharma Inc · NCT05382559 Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Phase 1/Phase 2 · UCLA Hematology Oncology Santa Monica ( Site 1205) · Merck Sharp & Dohme LLC · NCT06596694 A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Phase 1 · UCLA Santa Monica Medical Center · Kura Oncology, Inc. · NCT06655246 Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Phase 2/Phase 3 · UCLA Medical Centre-Santa Monica · Celgene · NCT03435796 A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resist
Phase 3 · Merck Sharp & Dohme LLC · NCT06136650 Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Particip
Phase 1/Phase 2 · Merck Sharp & Dohme LLC · NCT06353386

Look up another city

Look up another condition